Ardelyx to participate in upcoming investor conferences

WALTHAM, Mass., Sept.

01, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc.

NASDAQ:ARDX, (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participatio…